NCT02579122View on ClinicalTrials.gov

REVIparin-BRIDging-in a General Practice Setting in GErmany

TerminatedOBSERVATIONAL
Enrollment

77

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Thromboembolism
Trial Locations (11)

12555

Research Facility 52, Berlin

14052

Research facility 49, Berlin

44649

Research Facility 163, Herne

45219

Research facility 136, Essen

45968

Research facility 139, Gladbeck

47669

Research facility 119, Wachtendonk

Research facility 125, Wachtendonk

47798

Research facility 123, Krefeld

06188

Research Facility 82, Landsberg

04109

Research facility 84, Leipzig

01683

Research facility 70, Nossen

Sponsors

Lead Sponsor

Mylan Inc.
All Listed Sponsors
collaborator

Winicker Norimed GmbH

INDUSTRY

lead

Mylan Inc.

INDUSTRY